Newcastle University spin-out Atelerix was launched seven years ago by co-founders professor Che Connon, Dr Steve Swioklo and Dr Mick McLean, who set about making waves in the cell preservation market ...

Equities research analysts at HC Wainwright raised their Q4 2024 earnings estimates for shares of Legend Biotech in a report ...

( MENAFN - Investor Ideas) Investorideas ( ), a go-to platform for big investing ideas for stock traders, including biotech and medical tech Stocks reports on trading and news for Aethlon Medical, Inc ...

Stephens reiterated their equal weight rating on shares of Exelixis (NASDAQ:EXEL – Free Report) in a research report report ...

Royal Philips , a global leader in health technology, announced a collaboration with Tend®, a top-rated and in-demand full service dental practice, to bring Philips Zoom!, the No.1 patient-requested ...

Theradaptive, a Maryland-based, privately held, clinical-stage biologics company, today announced the initiation of patient dosing in Maryland for the ongoing OASIS Phase I/II clinical trial assessing ...

NextCell Pharma AB (publ) (NXTCL or NextCell) publishes its Interim Report 1 for the period September 1, 2024 - November 30, 2024. The report is available on the company's website: ...

Vortex Biotech Holdings, (‘Vortex’, or ‘the Company’), a leading oncology liquid biopsy company, is pleased to announce the appointment of Nigel Brooksby as Non-Executive Chairman. Nigel is an ...

The European Laboratory Research & Innovation Group (ELRIG), a not-for-profit, volunteer-led organisation for the drug discovery community, today announced the keynote speakers for Research & ...

Cell therapy company Aurion Biotech is moving forward with plans to IPO despite a pending lawsuit from one of its existing investors. The eye-disease-focused company plans to list on the New York ...

This is especially problematic in cases of blocked blood vessels, which can repeatedly starve large areas of the heart of oxygen and nutrients, killing the cardiomyocytes there. This leads to a ...

The new biotech has been set up to develop a T-cell therapy platform that aims to overcome the shortcomings of current approaches in the treatment of solid tumours, drawing on Campbell's expertise ...